title: Mutations in the 'a' determinant of hepatitis B surface antigen among Chinese infants receiving active postexposure hepatitis B immunization.
abstract: Twenty-four infants who became positive to the surface antigen of hepatitis B virus (HBsAg) despite a complete course of active postexposure immunization with plasma derived hepatitis B vaccine were studied. The polymerase chain reaction amplified products of the common neutralizing epitope 'a' determinant of HBsAg (Nucleotide 419-598) from serum samples were sequenced and analyzed for nucleotide mutations. Four cases (16.7%) had mutations that led to amino acid substitutions between codons 124 and 147. Only one case (N1) showed a substitution at codon 145 (from glycine to arginine, 145R), the other three were at codons 126-129. The mother of N1 was co-infected with the wild type and the mutant virus. Five years later, serum of N1 showed only the wild type virus. There was no significant relationship between the mutation rate and the anti-HBs response to hepatitis B vaccination. Results suggest that without immune selective pressure, 145R variant was not frequently observed, and was not stable. Mutation in the 'a' determinant was not an important cause of failure to prevent maternal-infant transmission of HBV by active postexposure hepatitis B immunization in Chinese children.
authors.affiliation: Department of Molecular Virology, Shanghai Medical University, People's Republic of China.
authors.forename: J W
authors.initials: JW
authors.lastname: He
authors.forename: Q
authors.initials: Q
authors.lastname: Lu
authors.forename: Q R
authors.initials: QR
authors.lastname: Zhu
authors.forename: S C
authors.initials: SC
authors.lastname: Duan
authors.forename: Y M
authors.initials: YM
authors.lastname: Wen
mesh_terms: D000595:Amino Acid Sequence; D002681:China; D000939:Epitopes / Q000235:genetics; D006509:Hepatitis B / Q000517:prevention & control; D006514:Hepatitis B Surface Antigens / Q000737:chemistry / Q000235:genetics*; D017325:Hepatitis B Vaccines / Q000627:therapeutic use; D006515:Hepatitis B virus / Q000235:genetics*; D006801:Humans; D007114:Immunization; D007223:Infant; D007231:Infant, Newborn; D008969:Molecular Sequence Data; D009154:Mutation; D017211:Treatment Failure
chemical_list: D000939:Epitopes; D006514:Hepatitis B Surface Antigens; D017325:Hepatitis B Vaccines